26.03.2021 • NewsLummus Technology

Lummus wins China EB Contract

Lummus Technology has won a contract for its proprietary EBOne ethylbenzene process from a firm in China’s Jiangsu province that will build a unit for 508,000 t/y of EB. A start-up date was not revealed. Lummus said the Chinese company has previously licensed its technologies, including the BP paraxylene process and Chevron Lummus Global’s Isocracking technology.

“We look forward to continuing to provide our world-class technology to customers in China, a critical market for us now and in the future,” said Lummus Technology’s president and CEO Leon de Bruyn. Under the terms of the contract, Lummus will provide a technology license, basic engineering, training and related site services.

The liquid-phase EBOne process uses a fixed-bed UOP zeolite catalyst system. Lummus said the process has low investment requirements, provides high yields and is energy-efficient. It also virtually eliminates the formation of xylene impurities, resulting in an EB product of high quality. More than 30 commercial EBOne plants are currently in operation worldwide.

In separate news, Lummus Technology has announced the start-up of a CDAlky C5 alkylation unit at Valero’s St. Charles refinery in Norco, Louisiana, USA.

The facility is the world’s first C5 CDAlky unit and Lummus’ first CDAlky unit in the US. The Texas-based engineering group developed the alkylation technology to process low value C5 feedstock at its pilot-scale facility in Pasadena. The technology reacts light olefins streams from refinery sources such as fluid catalytic cracking units, or from steam cracking units, with iso-paraffins to produce motor fuel alkylate.

Author: Elaine Burridge, Freelance Journalist

Lummus Technology is licensing its EBOne ethylbenzene process to an undisclosed...
Lummus Technology is licensing its EBOne ethylbenzene process to an undisclosed Chinese company. The firm in Jiangsu province will build a unit for 508,000 t/y of EB – a startup date was not revealed. Lummus has also started up the world’s first C5 CDAlky unit in the US. (c) Frauke Feind

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.